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Purpose: Due to the seroepidemiological shift in hepatitis A (HA), its severity, 
mortality, and complications have increased in recent years. Thus, the aim of this 
study was to identify predictive factors associated with poor prognosis among pa-
tients with HA. Materials and Methods: A total of 304 patients with HA admit-
ted to our institution between July 2009 and June 2011 were enrolled consecutive-
ly. Patients with complications defined as acute liver failure (ALF) were evaluated, 
and mortality was defined as death or liver transplantation. Results: The mean age 
of patients (204 males, 100 females) was 32 years. Eighteen (5.9%) patients had 
progressed to ALF. Of the patients with ALF, 10 patients (3.3%) showed spontane-
ous survival while 8 (2.6%) died or underwent liver transplantation. Multivariate 
regression analysis showed that Model for End-Stage Liver Disease (MELD) and 
systemic inflammatory response syndrome (SIRS) scores were significant predic-
tive factors of ALF. Based on receiver operating characteristics (ROC) analysis, a 
MELD ≥23.5 was significantly more predictive than a SIRS score ≥3 (area under 
the ROC: 0.940 vs. 0.742, respectively). In addition, of patients with a MELD 
score ≥23.5, King’s College Hospital criteria (KCC) and SIRS scores were predic-
tive factors associated with death/transplantation in multivariate analysis. Conclu-
sion: MELD and SIRS scores ≥23.5 and ≥3, respectively, appeared to be related to 
ALF development. In addition, KCC and SIRS scores ≥3 were valuable in predict-
ing mortality of patients with a MELD ≥23.5.
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INTRODUCTION
The hepatitis A virus (HAV) is the most common cause of acute hepatitis world-
wide.1 Less than 30% of infected young children show symptomatic hepatitis, 
while --80% of infected adults manifest severe acute hepatitis.2,3 Recently, we ob-
served an increased incidence of hepatitis A (HA) in adults. This is mostly due to 
the seroepidemiological shifts associated with rapid economic development. With 
the increased incidence of HA in adults, the severity, mortality and complications 
are increasing compared with previous periods. In fact, in Korea, there was an out-
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exclusions, a total of 304 patients were included in the anal-
yses. Data were collected prospectively and entered into a 
dedicated database. Demographic data, baseline laboratory 
data, and underlying medical problems, such as diabetes 
mellitus (DM) and chronic viral hepatitis, at diagnosis were 
recorded. The following variables were recorded at the time 
of hospital admission: body temperature, pulse, hemoglobin, 
RDW, white blood cell (WBC) counts, platelet counts, pro-
thrombin time (international normalized ratio, INR), total 
bilirubin, alanine aminotransferase (ALT), aspartate amino-
transferase (AST), alkaline phosphatase, albumin, and cre-
atinine. 
All HA patients received standard symptomatic treat-
ment. Nevertheless, when ALF developed, we performed 
an artificial supportive therapy such as molecular adsorbent 
recirculating system (MARS®; Gambro, Lakewood, CO, 
USA) for hepatic function recovery or as a bridge to liver 
transplantation. 
Our study protocol was consistent with the ethical guide-
lines of the 1975 Declaration of Helsinki and was approved 
by the independent Institutional Review Board of our insti-
tute. 
Definitions
The diagnosis of HA was based on the detection of serum 
IgM antibodies against HAV measured by an enzyme im-
munoassay (Abbott Laboratories, North Chicago, IL, USA). 
The clinical diagnosis of ascites was made by the presence 
of shifting dullness of fluid in the abdomen or the presence 
of fluid thrill. Ultrasound examination of the abdomen was 
performed when clinical signs for ascites were ambiguous. 
Hepatic encephalopathy (HEP) was graded from 1 to 4 ac-
cording to the West-Hevan criteria.16 Patients with compli-
cations defined as ALF were evaluated, and mortality was 
defined as death or liver transplantation. ALF was defined 
as coagulation abnormality (INR ≥1.5) and any degree of 
HEP.17 The definition of acute renal failure was based on an 
increase in serum creatinine >0.5 mg/dL over the baseline 
value, or an increase of more than 50% over the baseline 
value.18
The clinical parameters and first available laboratory tests 
at diagnosis were used to calculate the MELD score, KCC 
and SIRS score. The MELD score was calculated using the 
website calculator {(http://www.unos.org/resources/meld-
PeldCalculator.asp); MELD score=3.8×log [total bilirubin 
(mg/dL)]+11.2×log (INR)+9.6×log [creatinine (mg/dL)]+ 
6.43; any value less than one was given a value of 1}.19 The 
break of HA in 2008; it has become a very important public 
health problem.4
The main complication of HAV infection is acute liver 
failure (ALF). Although HAV-related ALF spontaneously 
resolves more frequently than ALF of another origin, as 
many as 50% of HAV patients with ALF may die or require 
emergency liver transplantation.5,6 In addition, HAV-related 
ALF progresses faster than ALF caused by other etiolo-
gies.7 Thus, it is both difficult and important to identify pa-
tients in need of urgent liver transplantation. Traditionally, 
the Model for End-Stage Liver Disease (MELD) and King’s 
College Hospital criteria (KCC) scores have been used for 
predicting ALF prognosis.8 In recent years, however, vari-
ous prognostic indicators, including systemic inflammatory 
response syndrome (SIRS), have been proposed for the 
evaluation of ALF.9 However, as mentioned earlier, since 
rapid disease progression and prognosis of HAV-related 
ALF is different than other origin-related ALF, alternative 
or additional prognostic markers are required. 
Red blood cell distribution width (RDW) originally rep-
resented the size variation of all red blood cells and was rou-
tinely performed as part of a complete blood cell count.10 
Recently, several studies have demonstrated that RDW can 
serve as a novel, independent predictor of prognosis in pa-
tients with cardiovascular diseases, acute kidney injury and 
sepsis.11-13 These conditions are often present in patients with 
liver disease, correlate with the severity of the disease, and 
are associated with a worse prognosis.14 However, to our 
knowledge, the relevance of RDW to HAV infection prog-
nosis and ALF has rarely been addressed.
The aim of this investigation was to reassess factors pre-
dicting ALF development and mortality in patients with 
HA by assessing several clinical factors, including prognos-
tic models.
MATERIALS AND METHODS
　　　
Patients
Between July 2009 and June 2011, a total of 319 patients 
with HA diagnosed at Severance Hospital, Yonsei Universi-
ty College of Medicine, Seoul, Korea, were consecutively 
enrolled in this study. Of these, patients with the following 
conditions were excluded: 1) under 18 years old, 2) history 
of excessive alcohol intake (more than 50 g of alcohol per 
day over 10 years),15 3) referred patients with previously di-
agnosed ALF, and 4) an incomplete medical record. After 
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velopment. Odds ratios (ORs) and corresponding 95% con-
fidence intervals (CIs) are indicated. Receiver operating 
characteristics (ROC) curves and area under the ROC (AU-
ROC) were used to identify which variables had the best 
discrimination capacity to predict ALF development. All 
two-sided p values were considered significant if  <0.05. Sta-
tistical analyses were performed using SPSS software (ver. 
18.0; SPSS Inc., Chicago, IL, USA).
 
RESULTS
 
Baseline characteristics of patients with/without ALF
Baseline characteristics of the 304 HA patients are summa-
rized in Table 1. The mean ages of the non-ALF (n=286, 
94.1%) and ALF groups (n=18, 5.9%) were 32±8 and 34±8 
years, respectively, and did not show significant difference 
(p=0.340). The proportion of males and mean body mass 
index (BMI) were not significantly different between the 
groups. The number of patients with DM was higher in the 
ALF group compared with the non-ALF group (p=0.016). 
KCC for non-acetaminophen-related ALF was defined as 
follows: A) prothrombin time >100 seconds (INR >6.5) or 
B) if any three of the following were present: 1) age <10 or 
>40; 2) cause: non-A, non-B hepatitis/idiosyncratic drug re-
action, 3) jaundice to encephalopathy >7 days, 4) prothrom-
bin time >50 s (INR >3.5), or 5) serum bilirubin >17.5 mg/
dL.20 The presence of SIRS was defined as two or more of 
the followings: temperature <36°C or >38°C, heart rate >90 
beats/min, leukocyte count <4×103/mm3 or >12×103/mm3, 
and tachypnea >20 breaths/min or PaCO2 <4.3 kPa.5 The 
number of SIRS components was fulfilled upon admission. 
Each patient was given a SIRS score depending on the 
number of SIRS components fulfilled at diagnosis.21
Statistical analyses
Data are expressed as means±standard deviation or n (%) 
unless otherwise stated. Student’s t-test was used to com-
pare continuous variables, and the chi-square test (or Fish-
er’s exact test) was used for categorical variables. Univari-
ate and subsequent multivariate logistic regression analyses 
were used to determine independent predictors of ALF de-
Table 1. Baseline Characteristic of the Patients at Diagnosis According to Outcome
Total (n=304)
Non-ALF 
(n=286, 94.1%)
ALF (n=18, 5.9%) p value
Age, yrs 32±8 32±8 34±8 0.340 
Male (%)  204 (66.9)  191 (66.8)    13 (72.2) 0.424 
Diabetes mellitus (%)  10 (3.3)    7 (2.4)      3 (16.7) 0.016 
Body mass index (kg/m2) 23.25±3.82 23.18±3.79 24.40±4.13 0.204 
HBsAg positivity (%)  20 (6.6)  17 (6.0)      3 (16.7) 0.106 
Anti-HCV positivity (%) 0 (0) 0 (0) 0 (0)
Acute kidney injury (%)    34 (11.2)  21 (7.3)    13 (72.2) 0.001 
Biochemical variables
    Total bilirubin (mg/dL)   4.80±5.37   4.5±5.0   7.5±8.3 0.021 
    Albumin (g/dL)   3.9±0.4   3.9±0.4   3.2±0.4 0.001 
    Aspartate aminotransferase (IU/L)   2849±3631   2606±3190   6718±6899 0.001 
    Alanine aminotransferase (IU/L)   2784±2059   2689±1992   4279±2550 0.001 
    Prothrombin time (INR)   1.29±0.62   1.18±0.32   3.00±1.40 0.001 
    Platelet (103/mm3) 180.99±76.01 182.44±76.04 157.89±73.83 0.184 
    Creatinine (mg/dL)   1.3±1.9   1.2±1.5   3.2±3.8 0.010 
    White blood cells (103/mm3)   6220.91±4986.64   5775.86±4064.08   13292.22±10489.74 0.008 
    Hemoglobin (g/dL) 14.6±1.6 14.7±1.5 14.2±2.5 0.396 
    RDW of  ≥13.5, n (%)    72 (23.6)    61 (21.3)    11 (61.1) 0.001 
Prognostic score
    MELD score 15.11±8.15 13.87±6.29 34.78±9.30 0.001 
    KCC fulfilled (%)    5 (3.3) 0 (0)      5 (27.8) 0.001 
    SIRS score   0.6±0.9   0.5±0.9   1.7±1.2 0.002 
ALF, acute liver failure; HBsAg, hepatitis B virus surface antigen; anti HCV, anti hepatitis C virus; RDW, red blood cell distribution width; MELD, Model for 
End-Stage Liver Disease; KCC, King’s College Hospital criteria; SIRS, systemic inflammatory response syndrome; INR, international normalized ratio.
Values are expressed as mean±SD or n (%).
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ated with ALF development. On univariate logistic regres-
sion analysis, DM (p=0.004), ALT (0.008), albumin (p= 
0.001), RDW >13.5 (p=0.001), MELD score (p=0.001), 
KCC (p=0.001), and SIRS score (p=0.001) were significant-
ly associated with ALF development. In stepwise multivari-
ate analysis, only the MELD (OR 1.149, CI 1.055--1.250, p= 
0.001) and SIRS scores (OR 2.160, CI 1.094--4.267, p= 
0.027) showed significant correlation. The sensitivities, spec-
ificities, positive predictive values (PPV), and negative pre-
dictive values (NPV) are shown in Table 3. A MELD score 
≥23.5 was superior to a SIRS score ≥3 in terms of predict-
ing the development of complications (AUROC 0.940 vs. 
0.742). 
Predictive factors associated with death/transplantation
Data of patients with a MELD score ≥23.5 were analyzed 
with regard to mortality. Based on a stepwise multivariate 
analysis, KCC (OR 53.353, CI 1.735--1640.878, p=0.023) 
and SIRS score (OR 3.564, CI 1.152--11.030, p=0.027) 
showed a significant correlation (Table 4). In ROC analysis, 
Hepatitis B virus surface antigen positivity was 17 (6.0%) 
and 3 (16.7%), respectively. Total bilirubin, albumin, AST, 
ALT, prothrombin time (INR), creatinine and WBC count, 
and RDW ratio >13.5 were significantly higher in the ALF 
group (all p-values <0.05). Patients with ALF had higher 
MELD scores (34.78±9.30 vs. 13.87±6.29; p=0.001), ful-
filled KCC (0 vs. 5; p=0.001), and SIRS scores (0.5±0.9 vs. 
1.7±1.2; p=0.002) than patients without ALF. 
Clinical outcomes
Clinical outcomes are presented in Fig. 1. Of the 304 pa-
tients enrolled, 286 (94.1%) showed spontaneous recovery 
without ALF, whereas ALF occurred in 18 (5.9%) patients. 
Mean duration from the first clinical manifestation to ALF 
onset was 4.5±1.5 days. Of the ALF patients, 10 (3.3%) 
showed spontaneous survival while 8 (2.6%) died during 
hospitalization or underwent liver transplantation. 
Predictive factors associated with development of ALF
Table 2 shows the predictive indicators significantly associ-
Fig. 1. Patient enrollment and clinical outcomes. ALF, acute liver failure.
Table 2. Multivariate Logistic Regression of Predictive Factors Associated with Acute Liver Failure
Risk factors OR 95% CI p value
Diabetes mellitus (%) 0.294 0.014--6.003 0.426
Biochemical variables
    Alanine aminotransferase (IU/L) 1.000 1.000--1.001 0.075
    Albumin (g/dL) 0.491 0.047--5.138 0.553
    RDW of  ≥13.5, n (%) 4.458   0.716--27.776 0.109
Prognostic score
    MELD score 1.149 1.055--1.250 0.001
    KCC fulfilled (%) 3.43E+09      0.001--999.999 0.292
    SIRS score 2.160 1.094--4.267 0.009
OR, odds ratio; CI, confidence interval; RDW, red blood cell distribution width; MELD, Model for End-Stage Liver Disease; KCC, King’s College Hospital 
criteria; SIRS, systemic inflammatory response syndrome.
Table 3. Predictive Accuracy of Acute Liver Failure
Parameter Cut-off value Sensitivity (%) Specificity (%) PPV (%) NPV (%) AUROC
MELD score 23.5 94.4 94.1 97.1 99.7 0.940 
SIRS score   3.0 33.3 98.3 55.5 90.4 0.742 
PPV, positive predictive value; NPV, negative predictive value; AUROC, area under the receiver operating characteristics; MELD, Model for End-Stage Liver 
Disease; SIRS, systemic inflammatory response syndrome.
Excluded 15 patients:
  1) Age <18 years (n=7)
  2) Excessive alcohol intake history (n=3)
  3) Referred patients with ALF (n=3)
  4) Incomplete medical record (n=2)
Acute hepatitis A (n=319)
Non-ALF (n=286, 94.1%) ALF (n=18, 5.9%)
Spontaneous survival (n=10, 3.3%) Death/transplant (n=8, 2.6%)
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in patients with HA, although the predictive power was low-
er (AUROC 0.742) than that of the MELD score (AUROC 
0.940). In addition, the SIRS score is useful in predicting 
mortality in patients with high MELD scores (≥23.5), re-
vealed by stepwise multivariate analysis. A SIRS score ≥3 
is highly predictive of spontaneous survival; these patients 
also have a low risk of ALF development. As a result of its 
high negative predictive value (90.4%), the SIRS score may 
have a potential role as a ‘gatekeeper’ when considering pa-
tient transfer to a tertiary liver transplant center. However, its 
relatively lower sensitivity indicates that it cannot complete-
ly replace the MELD or KCC as definitive listing criteria. 
The MELD score has been a validated predictive model 
of short-term mortality in patients with cirrhosis and has 
been used for ranking donor organ allocation in patients 
awaiting liver transplantation.27,28 Whether MELD is also 
useful in cases of ALF is controversial. Dhiman, et al.29 re-
ported that the MELD score is less useful for accurately pre-
dicting ALF outcome due to acute viral hepatitis, whereas 
Katoonizadeh, et al.30 proposed that MELD has an excel-
lent prognostic value in terms of predicting the outcome in 
adult patients with non-acetaminophen induced ALF. In the 
current study, the MELD score was a powerful tool for pre-
dicting ALF development in patients with HA compared to 
DM, ALT, albumin, RDW ≥13.5, and the SIRS score.
Recently, several studies showed that RDW can reflect the 
level of inflammation and predict mortality in critically ill 
patients.31 Although the mechanism of the association be-
tween RDW and mortality remains unclear, RDW is an at-
tractive tool because it is inexpensive and easy to check. 
Thus, we attempted to evaluate the relevance of RDW to 
prognosis in HAV infections. In our study, a RDW ratio 
>13.5 was significantly more frequent in the ALF group 
(61% vs. 21.3%, p=0.001), although a RDW ≥13.5 lost its 
predictive power in stepwise multivariate analysis. MELD 
and SIRS scores are believed to have a too-strong effect on 
ALF development. However, this study was valuable be-
cause we evaluated RDW as a predictor of HA for the first 
time.
Previous studies have suggested that the presence of chron-
ic hepatitis B or C and age are major risk factors for ALF de-
a SIRS score ≥3 was superior to fulfilled KCC in predicting 
death/transplantation (AUROC 0.803 vs. 0.731). The sensi-
tivity, specificity, PPV, and NPV of the SIRS score ≥3 were 
87.5%, 73.1%, 50.0%, 95.0%, respectively.
DISCUSSION
ALF is a rare but potentially fatal complication of acute 
hepatitis for which liver transplantation is the only defini-
tive therapy.22 In Asia, viral hepatitis has been a major cause 
of ALF, whereas acetaminophen has been the most com-
mon cause of ALF in western countries.23 ALF from HA 
occurs in --0.1--0.3% of all infections but increased signifi-
cantly in 2008 in Korea due to increased HAV infection in 
adults along with decreased opportunity for HAV infection 
in younger individuals.24 Thus, HA is not just a benign dis-
ease that can be resolved by conservative treatment; it needs 
to be aware of the potential of morbidity and mortality.
Many clinical and investigational variables have been 
proposed worldwide to predict outcome of patients with 
HA, but their accuracy and feasibility are still under debate. 
Our study was carried out prospectively to identify factors 
influencing ALF development and mortality in HA patients 
by analyzing several clinical factors, including prognostic 
models. An interesting point of this study is that we investi-
gated variable factors such as DM, BMI, RDW, and the 
SIRS score, which had not yet been applied to prediction of 
HA outcome. Recently, the SIRS score, the clinical mani-
festation of inflammation, was reported to be associated 
with the prognosis of ALF patients.25 Several studies have 
revealed that SIRS worsens the grade of HEP and increases 
the mortality rates as the number of SIRS fulfilled compo-
nents increases. Rolando, et al.9 reported that mortality in 
ALF patients increases with a greater magnitude of SIRS in 
both acetaminophen and other etiologies. Moreover, Craig 
et al.26 showed that the SIRS score is useful for identifying 
patients with a poor prognosis in paracetamol-induced ALF 
and effective triage markers following a paracetamol over-
dose. Our present findings agree with those studies. The 
SIRS score was an effective predictor of ALF development 
Table 4. Multivariate Logistic Regression of Predictive Factors Associated with Mortality  
OR 95% CI p value
  KCC fulfilled (%) 53.353   1.735--999.999 0.023
  SIRS score   3.564 1.152--11.030 0.027 
OR, odds ratio; CI, confidence interval; KCC, King’s College Hospital criteria; SIRS, systemic inflammatory response syndrome.
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